An Israeli scientist who developed a ground-breaking technology, known as ‘liver-on-chip’, which is capable of assessing the toxicity of products without recourse to animal testing has announced that he is on course to deliver two new alternative testing methods by 2018, according to a report published by Arutz Sheva 7.

Developed by Yaakov Nahmias’ firm Tissue Dynamics, brain-on-chip and heart-on-chip will simulate their human-organ equivalents, including functional neurons and vasculature.

“Our goal is to have these three major organs, which are the target of a lot of drugs. In 2019 we will complete a large facility for manufacturing the chips,” Nahmias told Arutz Sheva 7. “There is a lot of interest.”